ALLISON KIDNEY: Open Payments
NPI 1588120497 · SNOW HILL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 25 payments from 10 companies in 2025. Trend: 2023 $295 · 2024 $631 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $124 |
| Novo Nordisk Inc | 6 | $108 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Exact Sciences Corporation | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: QULIPTA, Cologuard Collection Kit, Ozempic, BREZTRI, JARDIANCE, Rybelsus, Wegovy, GARDASIL 9.
Industry payments across MD — which companies pay providers there.
